---
title: "Four new stocks in Hong Kong are set to be issued on the same day! LAIFUAL was oversubscribed by 4,576 times, and TH MEDICAL-B was oversubscribed by 1,792 times"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290817604.md"
description: "Four new stocks in the Hong Kong stock market have their public offerings closing today. LAIFUAL was oversubscribed 4,576 times with 183,000 applicants; XUNLONG SCITECH was oversubscribed 2,136 times with 180,000 applicants; TH MEDICAL-B was oversubscribed 1,792 times with 128,000 applicants; JIANGXI BIO was oversubscribed 477 times with 78,000 applicants"
datetime: "2026-06-25T10:45:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290817604.md)
  - [en](https://longbridge.com/en/news/290817604.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290817604.md)
---

# Four new stocks in Hong Kong are set to be issued on the same day! LAIFUAL was oversubscribed by 4,576 times, and TH MEDICAL-B was oversubscribed by 1,792 times

Today, 4 new stocks have closed for public offering. According to market news, LaiFuaL (3952.HK), a core component provider for China Robotics (Core Stock) Precision Transmission, has recorded an oversubscription of 4,576 times, attracting 183,000 subscribers.

Caviar company XunLong SciTech (6715.HK) has recorded an initial oversubscription of 2,136 times for its public offering, with 180,000 subscribers as well.

ZhenJianKang Medical (2697.HK), a manufacturer of percutaneous surgical robots in China, has recorded an initial oversubscription of 1,792 times for its public offering; a total of 128,000 people have subscribed.

Jiangxi Bio (6915.HK), the largest provider and exporter of human tetanus antitoxin ("human TAT") in China, has recorded an oversubscription of 477 times for its public offering, with 78,000 subscribers.

For more exclusive planning and expert columns in the stock channel, check for free \>\>

### Related Stocks

- [02697.HK](https://longbridge.com/en/quote/02697.HK.md)
- [03952.HK](https://longbridge.com/en/quote/03952.HK.md)
- [06915.HK](https://longbridge.com/en/quote/06915.HK.md)
- [06715.HK](https://longbridge.com/en/quote/06715.HK.md)

## Related News & Research

- [ZhenHealth's HK IPO tests global appetite for pre-revenue medical assets](https://longbridge.com/en/news/290939539.md)
- [Hong Kong's 'Hard Tech' Boom Is a Chaotic Mix of Real AI Hardware and Desperate Corporate Pivots](https://longbridge.com/en/news/290939355.md)
- [Heavyweights in Transition: Hong Kong's Financial and Property Sectors](https://longbridge.com/en/news/290670748.md)
- [Biotech Firms Push Weight-Loss and AI Pipelines Amid Buyback Wave](https://longbridge.com/en/news/291029476.md)
- [Trip.com sees decelerating sales growth in Q2, faces probe by Chinese regulators](https://longbridge.com/en/news/290842670.md)